Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Evaluate Pharmacokinetics of GLA5PR Tablet According to the Renal Function

NCT03963362 is registered in ClinicalTrials.gov with GL Pharm Tech Corporation as lead sponsor.

NCT NCT03963362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Evaluate Pharmacokinetics of GLA5PR Tablet According to the Renal Function
Lead sponsor
GL Pharm Tech Corporation
Phase
Phase 1
Overall status
Unknown status
Start date
September 17, 2019
Completion date
June 30, 2021
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain